Literature DB >> 9806019

Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus.

D E Jenkins1, R L Redman, E M Lam, C Liu, I Lin, A M Arvin.   

Abstract

Varicella immunization provided the opportunity to examine the kinetics of interleukin (IL)-10, IL-12 and interferon (IFN)-gamma production elicited during primary in vivo sensitization with proteins of varicella-zoster virus (VZV), a common human herpesvirus. VZV-specific IFN-gamma release and T cell proliferation were elicited by immunization and persisted through 15 months of follow-up. The induction of VZV-specific T cells and IgG antibodies was accompanied by transient increases in IL-10 and IL-12 production. T cell proliferation to VZV was significantly lower in adults at 15 months than in vaccinated children or naturally immune subjects and correlated with lower IFN-gamma responses in individual vaccinees. After primary immunity was induced, continued IL-12 production was not necessary to maintain the predominant Th1-type response elicited by VZV. Cytokine profiles observed during primary in vivo sensitization to VZV suggest that parallel increases in IFN-gamma and IL-10 may be important in the induction of immunity to some viral pathogens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806019     DOI: 10.1086/515702

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Influence of systemic immune and cytokine responses during the acute phase of zoster on the development of postherpetic neuralgia.

Authors:  Sheng-mei Zhu; Yong-min Liu; Er-dan An; Qing-lian Chen
Journal:  J Zhejiang Univ Sci B       Date:  2009-08       Impact factor: 3.066

2.  Modulation of major histocompatibility class II protein expression by varicella-zoster virus.

Authors:  A Abendroth; B Slobedman; E Lee; E Mellins; M Wallace; A M Arvin
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells.

Authors:  A Abendroth; I Lin; B Slobedman; H Ploegh; A M Arvin
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Interferon Gamma Prolongs Survival of Varicella-Zoster Virus-Infected Human Neurons In Vitro.

Authors:  Nicholas L Baird; Jacqueline L Bowlin; Taylor J Hotz; Randall J Cohrs; Don Gilden
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

Review 5.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

6.  Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.

Authors:  J G Smith; X Liu; R M Kaufhold; J Clair; M J Caulfield
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

7.  Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.

Authors:  A Henke; R Zell; G Ehrlich; A Stelzner
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

8.  Interferon gamma expression and clinical features in patients with acute retinal necrosis syndrome.

Authors:  Toshiaki Abe; Masami Sato; Yoko Saigo; Makoto Tamai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-08-20       Impact factor: 3.117

9.  Local immune responses and systemic cytokine responses in zoster: relationship to the development of postherpetic neuralgia.

Authors:  M Zak-Prelich; R C McKenzie; A Sysa-Jedrzejowska; M Norval
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

Review 10.  T-cell immunity to human alphaherpesviruses.

Authors:  Werner J D Ouwendijk; Kerry J Laing; Georges M G M Verjans; David M Koelle
Journal:  Curr Opin Virol       Date:  2013-05-08       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.